Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Consensus molecular subtype classification of colorectal adenomas.

Komor MA, Bosch LJ, Bounova G, Bolijn AS, Delis-van Diemen PM, Rausch C, Hoogstrate Y, Stubbs AP, de Jong M, Jenster G, van Grieken NC, Carvalho B, Wessels LF, Jimenez CR, Fijneman RJ, Meijer GA; NGS-ProToCol Consortium:.

J Pathol. 2018 Nov;246(3):266-276. doi: 10.1002/path.5129. Epub 2018 Aug 31.

2.

Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.

Jacobsen A, Bosch LJW, Martens-de Kemp SR, Carvalho B, Sillars-Hardebol AH, Dobson RJ, de Rinaldis E, Meijer GA, Abeln S, Heringa J, Fijneman RJA, Feenstra KA.

Sci Rep. 2018 May 14;8(1):7522. doi: 10.1038/s41598-018-24982-z.

3.

Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas.

Carvalho B, Diosdado B, Terhaar Sive Droste JS, Bolijn AS, Komor MA, de Wit M, Bosch LJW, van Burink M, Dekker E, Kuipers EJ, Coupé VMH, van Grieken NCT, Fijneman RJA, Meijer GA.

Cancer Prev Res (Phila). 2018 Jul;11(7):403-412. doi: 10.1158/1940-6207.CAPR-17-0317. Epub 2018 Apr 23.

PMID:
29685877
4.

Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.

Bosch LJW, de Wit M, Pham TV, Coupé VMH, Hiemstra AC, Piersma SR, Oudgenoeg G, Scheffer GL, Mongera S, Sive Droste JT, Oort FA, van Turenhout ST, Larbi IB, Louwagie J, van Criekinge W, van der Hulst RWM, Mulder CJJ, Carvalho B, Fijneman RJA, Jimenez CR, Meijer GA.

Ann Intern Med. 2017 Dec 19;167(12):855-866. doi: 10.7326/M17-1068. Epub 2017 Nov 21.

PMID:
29159365
5.

Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer.

Bosch LJW, Trooskens G, Snaebjornsson P, Coupé VMH, Mongera S, Haan JC, Richman SD, Koopman M, Tol J, de Meyer T, Louwagie J, Dehaspe L, van Grieken NCT, Ylstra B, Verheul HMW, van Engeland M, Nagtegaal ID, Herman JG, Quirke P, Seymour MT, Punt CJA, van Criekinge W, Carvalho B, Meijer GA.

Oncotarget. 2017 Jun 27;8(38):63140-63154. doi: 10.18632/oncotarget.18702. eCollection 2017 Sep 8.

6.

Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.

Lansdorp-Vogelaar I, Goede SL, Bosch LJW, Melotte V, Carvalho B, van Engeland M, Meijer GA, de Koning HJ, van Ballegooijen M.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):504-512.e11. doi: 10.1016/j.cgh.2017.07.011. Epub 2017 Jul 18.

PMID:
28733262
7.

Early detection: the impact of genomics.

van Lanschot MCJ, Bosch LJW, de Wit M, Carvalho B, Meijer GA.

Virchows Arch. 2017 Aug;471(2):165-173. doi: 10.1007/s00428-017-2159-2. Epub 2017 Jun 1. Review.

PMID:
28573511
8.

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.

Bosch LJ, Luo Y, Lao VV, Snaebjornsson P, Trooskens G, Vlassenbroeck I, Mongera S, Tang W, Welcsh P, Herman JG, Koopman M, Nagtegaal ID, Punt CJ, van Criekinge W, Meijer GA, Monnat RJ Jr, Carvalho B, Grady WM.

Clin Cancer Res. 2016 Sep 15;22(18):4612-22. doi: 10.1158/1078-0432.CCR-15-2703. Epub 2016 Apr 27.

9.

Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.

de Cuba EM, Snaebjornsson P, Heideman DA, van Grieken NC, Bosch LJ, Fijneman RJ, Belt E, Bril H, Stockmann HB, Hooijberg E, Punt CJ, Koopman M, Nagtegaal ID, Coupé VH, Carvalho B, Meijer GA.

Int J Cancer. 2016 Mar 1;138(5):1139-45. doi: 10.1002/ijc.29855. Epub 2015 Oct 23.

10.

Genomic landscape of metastatic colorectal cancer.

Haan JC, Labots M, Rausch C, Koopman M, Tol J, Mekenkamp LJ, van de Wiel MA, Israeli D, van Essen HF, van Grieken NC, Voorham QJ, Bosch LJ, Qu X, Kabbarah O, Verheul HM, Nagtegaal ID, Punt CJ, Ylstra B, Meijer GA.

Nat Commun. 2014 Nov 14;5:5457. doi: 10.1038/ncomms6457.

11.

Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.

de Cuba EM, Kwakman R, van Egmond M, Bosch LJ, Bonjer HJ, Meijer GA, te Velde EA.

Virchows Arch. 2012 Sep;461(3):231-43. doi: 10.1007/s00428-012-1287-y. Epub 2012 Jul 24. Review.

PMID:
22825001
12.

Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.

Bosch LJ, Mongera S, Terhaar Sive Droste JS, Oort FA, van Turenhout ST, Penning MT, Louwagie J, Mulder CJ, van Engeland M, Carvalho B, Meijer GA.

Cell Oncol (Dordr). 2012 Aug;35(4):309-15. doi: 10.1007/s13402-012-0092-6. Epub 2012 Jul 21.

PMID:
22821210
13.

DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.

Bosch LJ, Oort FA, Neerincx M, Khalid-de Bakker CA, Terhaar sive Droste JS, Melotte V, Jonkers DM, Masclee AA, Mongera S, Grooteclaes M, Louwagie J, van Criekinge W, Coupé VM, Mulder CJ, van Engeland M, Carvalho B, Meijer GA.

Cancer Prev Res (Phila). 2012 Mar;5(3):464-72. doi: 10.1158/1940-6207.CAPR-11-0315. Epub 2011 Dec 1.

14.

Molecular tests for colorectal cancer screening.

Bosch LJ, Carvalho B, Fijneman RJ, Jimenez CR, Pinedo HM, van Engeland M, Meijer GA.

Clin Colorectal Cancer. 2011 Mar 1;10(1):8-23. doi: 10.3816/CCC.2011.n.002. Review.

PMID:
21609931
15.

Fecal Tests: From Blood to Molecular Markers.

Young GP, Bosch LJ.

Curr Colorectal Cancer Rep. 2011 Mar;7(1):62-70. Epub 2011 Jan 18.

16.

Basic fibroblast growth factor-mediated overexpression of vascular endothelial growth factor in 1F6 human melanoma cells is regulated by activation of PI-3K and p38 MAPK.

Fontijn D, Bosch LJ, Duyndam MC, van Berkel MP, Janmaat ML, Boven E.

Cell Oncol. 2009;31(3):179-90. doi: 10.3233/CLO-2009-0477.

17.

Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.

Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van den Bosch SM, Carvalho B, Mongera S, Voncken JW, Meijer GA, de Bruïne AP, Herman JG, van Engeland M.

Carcinogenesis. 2009 Jun;30(6):1041-8. doi: 10.1093/carcin/bgp073. Epub 2009 Mar 27.

PMID:
19329758
18.

Disappearance of factor VIII autoantibodies preceding autoimmune haemolytic anaemia.

van den Brink EN, Turenhout EA, Wijn-Maas EC, van der Meer FJ, Voorberg J, Bosch LJ.

Haemophilia. 2000 Nov;6(6):698-701.

PMID:
11122400
19.

Congenital hypoplastic anemia: another example of autosomal dominant transmission.

Gojic V, van't Veer-Korthof ET, Bosch LJ, Puyn WH, van Haeringen A.

Am J Med Genet. 1994 Mar 1;50(1):87-9.

PMID:
8160759
20.

Hodgkin disease in the elderly. A registry-based analysis.

Erdkamp FL, Breed WP, Bosch LJ, Wijnen JT, Blijham GB.

Cancer. 1992 Aug 15;70(4):830-4.

PMID:
1643615
21.

Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease. Are they of independent prognostic value?

Wijlhuizen TJ, Vrints LW, Jairam R, Breed WP, Wijnen JT, Bosch LJ, Crommelin MA, van Dam FE, de Koning J, Verhagen-Teulings M.

Cancer. 1989 Mar 15;63(6):1150-3.

PMID:
2917317
22.

Factor VIII inhibitor postpartum.

Michiels JJ, Bosch LJ, van der Plas PM, Abels J.

Scand J Haematol. 1978 Feb;20(2):97-107.

PMID:
305611
23.

TREATMENT OF THROMBOCYTOPENIC PATIENTS WITH REPEATED PLATELET TRANSFUSIONS.

BOSCH LJ, EERNISSE JG, VAN LEEUWEN, LOELIGER EA, VAN ROOD JJ.

Rev Belg Pathol Med Exp. 1965 Apr;31:139-45. No abstract available.

PMID:
14324570
24.

RELATIONSHIP OF LEUKOCYTE GROUPS TO TISSUE TRANSPLANTATION COMPATIBILITY.

VAN ROOD JJ, VAN LEEUWEN A, EERNISSE JG, FREDERIKS E, BOSCH LJ.

Ann N Y Acad Sci. 1964 Nov 30;120:285-98. No abstract available.

PMID:
14233876
25.

[DURATION OF THROMBOCYTE SURVIVAL AND THROMOCYTE TRANSFUSION].

BOSCH LJ, FABER WR, VAN ROOD JJ, VERVLOET M.

Ned Tijdschr Geneeskd. 1963 Oct 26;107:2010-2. Dutch. No abstract available.

PMID:
14053560
26.

[Possibilities of the use of Cr-51 in the determination of the length of survival of thrombocytes].

BOSCH LJ, JANSZ A, LAMMERS HA, van LEEUWEN, van ROOD J.

Ned Tijdschr Geneeskd. 1963 Feb 16;107:321-4. Dutch. No abstract available.

PMID:
14014146

Supplemental Content

Loading ...
Support Center